Neuromodulation and Mindfulness Patients With AUD

Recruiting N/A Interventional Study
Alcohol Dependence
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
140 (estimated)
Sponsor
Charite University, Berlin, Germany · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Our primary objective is to integrate tVNS and mindfulness meditation within a structured mindfulness-based relapse prevention (MBRP) program for detoxified alcohol-dependent patients (AD). We aim to determine whether neuromodulation can enhance mindfulness-based relapse prevention compared to mindfulness practice alone. In this context, we will investigate potential changes in the interaction of …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Alcohol Dependence (ICD-10) * abstinence between 3 days and 12 months Exclusion Criteria: * current (last 12 months) substance use disorder/dependence * neurological disorders (e.g. epilepsy, neuropathy, multiple sclerosis) * current severe major depressive disorder, manic e…
Contacts

Annika Rosenthal

030 450 517040

annika.rosenthal@charite.de

CONTACT